Skip to main content

A systematic review of case reports of hepatic actinomycosis



Hepatic Actinomycosis (HA) is one of the infections that causes disorders in patients when diagnosed untimely and inappropriately.


Case reports on HA in patients published between 2000 and April 2020 were gathered by carrying out a structured search through PubMed/Medline.


Through a survey of the Medline database, 130 studies were identified and then, 64 cases with HA were included in the final analysis. Asia had the largest share of cases with 37.5% (24 reports), followed by Europe and the Americas. Affected patients were predominantly males (64%) and the overall mortality rate was 1% with only one male patient in his 50 s dying. Nearly all patients (92%) were immunocompetent. However, in four patients, the use of immunosuppressive medication led to depression of the immune system. Most of the patients (80%) experienced complications. In terms of the complications, the most frequent ones were previous history of abdominal surgery (32%) and foreign bodies in the abdominopelvic region (20%). Actinomyces israelii was the most common pathogen isolated from patients. Abdominal pain (66%), fever (62%), weight loss (48%), night sweat, malaise, and anorexia (14%) over about 3.1 months were the most frequently reported clinical symptoms. Extension to one or more surrounding organs was evident in 18 patients (28%). Histopathologic examination confirmed infection in 67% of the patients and samples obtained from liver puncture biopsy (32%) were most frequently used in diagnosis. Surgery or puncture drainage + anti-infection was the most common method to treat patients and penicillin, Amoxicillin, Doxycycline, and ampicillin were the most frequently used drugs to control infection.


HA should be considered in patients with a subacute or chronic inflammatory process of the liver. With accurate and timely diagnosis of infection, extensive surgery can be prevented.


Actinomyces spp. are opportunistic gram-positive, anaerobic, or facultatively anaerobic bacteria that usually colonize the upper respiratory tract or the gastrointestinal and female genital tract and typically infect males between 20 and 60 years old [1, 2]. Granulomatous inflammation, abscesses, contiguous spread, and formation of sinus tract fistulae are the distinguishing characteristics of chronic actinomycosis. This type of infection has been addressed in the research for more than 150 years with the most common agent being Actinomyces israelii [2,3,4]. Actinomyces have low pathogenicity and their infection has subacute manifestation. However, polymicrobial infections frequently occur in patients being involved with actinomycosis, promoting pathogenicity of these bacteria [3, 5]. Fortunately, drug resistance is not an issue in the treatment procedure and beta-lactams, particularly penicillin G or Amoxicillin, are extremely influential in Actinomyces spp., making them an ideal choice for treatment [6, 7]. Treatment of actinomycosis should focus on antibiotic therapy and surgery alone does not seem to be a suitable method for treatment, although in refractory cases, surgery can be a supporting therapy [3, 8].

While any site in body can be involved with actinomycosis, cervicofacial infection is the most common one. Other parts of the body prone to be infected with Actinomyces spp. are thorax, abdomen, pelvis, and the central nervous system [3, 4]. Abdominal infection occurs in 20% of cases and appendix and the ileocecal region are generally affected [9]. Hepatic involvement is usually uncommon and occurs after other intra-abdominal sites of infection. Hepatic Actinomycosis (HA) occurs in only 15% of the abdominal infections and, in total, makes up 5% of all actinomycosis cases [5, 10]. Diagnosis of HA is often challenging, because infection diagnosis is dependent on clinical manifestations and findings from imaging. Thus, it can be simply misdiagnosed as a primary liver cancer when it is in the form of a solitary tumor or metastatic with multiple imaging features [8, 11, 12]. In this regard, actinomycosis often mimics malignancy, tuberculosis, or nocardiosis due to its progressive and constant expansion that may form a cold abscess [7, 13]. Therefore, diagnosing HA in patients is usually challenging and in some cases, this leads to extensive surgery and permanent damage. The present research is the first systematic review aimed at studying the reported HA cases in different patients.


Literature search and inclusion criteria

In the present research, a Medline (via PubMed) search was carried out between the years 2000 and 2020. The keywords for search were taken from the National Library of Medicine’s Medical Subject Heading (MeSH) terms, titles, or abstracts through Boolean operators (and/or) including “Actinomyces” or “Actinomycosis” or “Actinomycotic”, and “Liver” or “Hepatic.” It should be noted that only studies in English language were included. Of the total 130 hits, 64 were included based on the inclusion criteria given in Fig. 1. The protocol for review employed in the present research was adopted from our recent article and a study conducted by Hickey et al. [14, 15].

Fig. 1

Flow chart of publication selection and their inclusion in the systematic review

Inclusion criteria

The systematic review was carried out by the given inclusion criteria: individual case reports on HA in different patients, full texts or abstracts of studies published in English, and online studies published on Medline (via PubMed) from 2000 up to April, 2020.

Exclusion criteria

The exclusion criteria were non-human studies, review articles, guidelines, systematic reviews or meta-analyses, actinomycosis without propagation of infection into the liver, and incomplete reported data (Fig. 1).

Study selection and data extraction

Two researchers (AS and ZC) screened the articles and when discrepancy was observed, they skimmed the paper or conference abstract as a case to be reviewed by both in collaboration. For each article, the following features were extracted and recorded through Excel software (Microsoft, Redmond, WA, USA): country, publication year, sex, age, causative pathogen, medical history and co-morbidities, clinical presentation, antibiotics treatment, surgery and drainage, diagnostic method, and outcome. The references of the articles were comprehensively surveyed to make sure that there were no additional cases remaining unidentified from the primary search.

Quality assessment

The critical checklist for appraisal put forward by the Joanna Briggs Institute (JBI) was adopted in order to assess the quality of studies [16].



In a survey of the Medline database, 130 cases were identified and then, 64 patients with HA were included in the final analysis based on the study criteria (Fig. 1). These individual cases were published from Bahrain, India, France, Italy and Portugal (one each), Canada, Germany, Greece, Romania, Spain, and Serbia (two each), the United Kingdom (three reports), Japan (four reports), China (five reports), Taiwan and Turkey (six each), Korea (seven reports) and finally the USA (16 reports). Accordingly, Asia had the largest share of cases with 37.5% (24 reports) followed by Europe and the Americas with 34% (22 reports) and 28% (18 reports), respectively. No case from the continents of Australia and Africa was detected. According to the findings of the present study, the overall mortality rate was 1% with only one male patient in his 50 s dying due to thoraco-pulmonary and HA condition that rapidly deteriorated and killed him before starting treatment. Our results also showed that only 36% of the patients were female and the other 64% were male. The mean age of patients was 51.6 years (ranging between 5 and 84) and 55% of the patients were 50 years of age or older (Table 1).

Table 1 Clinical, diagnosis, epidemiological and therapeutic features of patients with hepatic actinomycosis from individual cases

Primary or isolated HA (when a primary focus was not found) was reported in 61% of the patients, while in 20 (31%) and 4 (6%) patients, abdominopelvic actinomycosis with liver dissemination and disseminated infection were reported, respectively. Also, in one patient, actinomycosis of lungs directly invaded the liver parenchyma with IgG4-related hepatopathy through the diaphragm. Nearly all patients (92%) were immunocompetent; however, in four patients, the use of immunosuppressive medication prednisolone, plaquinil, prednisone, and tacrolimus led to depression of the immune system. In one patient, immunodepression by varicella was reported as the most likely reason for the acute onset of symptoms. On the other hand, most of the patients (80%) had complications with the most frequent one being previous history of abdominal surgery (32%), foreign bodies in the abdominopelvic region (20%) (Intrauterine Contraceptive Device (IUD) in nine cases, stenting of the bile duct in two cases, pancreatic duct stenting, and accidentally ingested fish bone) and diabetes (17%) (Fig. 2).

Fig. 2

The most common complications in patients with hepatic actinomycosis

Only 14 studies (22%) performed the species-level identification and A. israelii was the most common pathogen isolated from patients with eight reports, followed by A. naeslundii with two reports and A. cardiffensis, A. odontolyticus, and A. turicensis each with one case. Notably, in one study, the causative pathogen was reported to be of either A. naeslundii or A. viscosus species considering the fact that there was no difference between the two in Polymerase Chain Reaction (PCR) with 16 s rRNA primer set (Table 1). Finally, the infection was mixed with other organisms in 17 cases (26%) with the available information in Additional file 1: Table S4.

Clinical manifestations

The most common manifestations were abdominal pain (66%), fever (62%) and weight loss (48%). Other clinical manifestations of patients are displayed in Fig. 3. Initial laboratory observations revealed leukocytosis, anemia, and elevated alkaline phosphatase (ALP) in 43 (67%), 35 (55%), and 29 (45%) patients, respectively (Fig. 3). Onset was chronic or subacute with an extended duration of symptoms (mean ± SD = 3.1 ± 3.9 month) such that the shortest duration was one month and the longest 2 years. A more acute presentation (< 2 week) was reported in 15 (26%) cases (in six patients, the duration of onset of symptoms was not reported; therefore, they were excluded from the final analysis).

Fig. 3

Characteristic of patients with hepatic actinomycosis. RUQT Right upper quadrant tenderness, ALP alkaline phosphatase, AST aspartate transaminase, ALT alanine transaminase, CRP C-reactive protein, ESR erythrocyte sedimentation rate, CA carbohydrate antigen, AFP alpha-fetoprotein

In 18 patients (28%), the infection extended to one or more surrounding organs or tissues including diaphragm, abdominal wall, lungs, transverse colon, stomach with extension to the gastric muscularis propria, thorax, and inferior vena cava. For six other patients, it was assumed that hepatic abscess caused Thrombotic Thrombocytopenic Purpura (TTP), acute cardiac tamponade (in two cases), hepatic artery invasion with encasement of the portal vein and celiac and liver hilum adenopathies, hepatic vein and IVC thromboses, and finally right pulmonary empyema (Additional file 1: Table S1).


The diagnosis was confirmed by histopathologic examination of different specimens in 43 of 64 (67%) instances: liver puncture biopsy in 14 cases, liver lobe resection in 13 cases, laparoscopic or surgical tissue in 9 cases, and autopsy in one case. In six other patients, histopathologic examination of samples other than liver, including resected appendix, pipelle endometrial biopsy, pelvic tumor, adnexae, thoracoscopic lung biopsy, right salpingo-oophorectomy and bilateral salpingo-oophorectomy, small bowel resection, and appendectomy led to actinomycosis detection. Sulfur granules were reported from 36 (56%) patients. Although liver puncture biopsy was performed for 10 patients, it did not lead to the diagnosis of actinomycosis and in one patient, needle aspiration could not be performed, because the liver lesions suspicious for hydatid cyst were localized subcapsularly (Additional file 1: Table S1 presents all the findings from histopathological examinations).

In five (7.9%) other patients, the information obtained from culture and histopathologic examination led to the diagnosis of infection. Furthermore, culture alone diagnosed actinomycosis in seven patients (11%). Notably, culture was not used to diagnose infection in 24 (37%) patients and out of 40 patients for whom this method of diagnosis was used, only 18 (45%) cases came positive. Aspirate obtained from the hepatic abscess and tissue specimens resulted in positive culture for 12 and three patients, respectively. Blood, material spontaneously drained through a fistula between liver and skin, and pericardial fluid cultures also led to the diagnosis of actinomycosis in three other cases. The duration of positive culture was reported in only three patients, which was eight and 10 days for the aspirate obtained from the hepatic abscess of two patients and four days for pericardial fluid. Blood culture was reported in 13 instances and found positive in the detection of actinomycosis in only two (15%) cases.

Polymerase Chain Reaction (PCR) was used to confirm the diagnosis of infection in only one (1.6%) patient. In five (7.9%) other cases, culture system (API system in two cases and VITEK II system in two other patients) could not confirm the bacteria’s species and identification of the level of phenotypic species was impossible. Therefore, genomic identification was performed by 16S ribosomal RNA gene sequencing analysis. Finally, in three instances (4.6%) (Fig. 4), gram staining of transthoracic needle aspiration, hepatic lesion, and pleural fluid aspiration without the use of any other diagnostic method led to the identification of actinomycosis in the patients (Additional file 1: Table S1).

Fig. 4

Different methods that led to the diagnosis of hepatic actinomycosis. HE Histopathologic examination, PCR polymerase chain reaction

Medical imaging modalities of Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and ultrasound did not give a definitive diagnosis for any of the patients. Among the ultrasound, MRI, and CT information for the patients, the most frequent finding was a single abscess or mass (57%). The right lobe (52%) was the most frequently affected, followed by the left lobe (26%) and both lobes (21%). The imaging characteristics of HA were mainly mass-like and nodular (70% of cases), abscess-like (67%), low density (50%) and solid tumor-like (32%). In addition, a few (26%) hypodense cystic cases were observed. The available information on medical imaging modalities is shown in Additional file 1: Table S2.

Information from the patients’ clinical signs, imaging, and liver puncture biopsy led to the suspicion of liver malignant tumor or liver metastasis, hepatic inflammatory pseudotumor, and pyogenic liver abscesses in 32 (50%), seven (11%) and 20 (31%) cases, respectively (Fig. 3). All the findings that gave the diagnosis of HA in patients are fully provided in Tables S1 and S2.


From the data available in the literature, in a total of 64 cases, surgery or puncture drainage + anti-infection, liver lobe resection + anti-infection, anti-infection alone, and liver lobe resection alone were used for 30 (46%), 14 (21%), 18 (28%), and one patient, respectively. One of the patients died before starting the treatment and in another case, no information was reported about the type of drug the patient was taking. Therefore, they were excluded from the final analysis. Antibiotics including penicillin (32 patients, 51%), Amoxicillin (17 patients, 27%), Doxycycline and ampicillin (six patients, 9%) were the most frequently used drugs for the treatment of HA in patients (Fig. 3). Duration of treatment was state in 45 cases and the mean duration of treatment was 5.5 months (mean ± SD = 5.5 ± 3.8 months ranging from one week to 24 months). As mentioned, with regard to the clinical and laboratory symptoms, pyogenic liver abscesses were suspected in a number of patients. For this reason, the use of empirical therapies to cover a wide range of bacteria was prescribed for them. However, in almost all of the cases, no improvement was achieved. Additional file 1: Table S3 covers these empirical treatments and their implications.


HA is a very rare abdominal actinomycosis type and generally occurs after abdominal infection [36, 38]. Our results showed any age group could be infected, although patients over the age of 55 seemed to be more prone to this infection. Also, the rate of infection was higher in men between 50 and 70 years as the most susceptible group. The reason for the male predominance was uncertain, but all forms of actinomycosis were recognized in observations [61]. Previous studies also reported that HA was usually seen in males, but the most common age range for the infection in these studies was 30–50 years [47, 71]. These studies were conducted in more distant years than the present research (1990–2005). Therefore, it seems that in recent years, the average age of men for HA has increased. On the other hand, females have been more often affected probably due to a long-term use of the IUD and endometrial colonization with A. israelii [51, 72]. Our analysis showed that although the diagnosis was often made late and as a result, a delay occurred in initiating the therapy, the outcome was totally acceptable and the mortality rate was 1.5%. (1/64). In a recent study that was conducted with HA cases from 1966 to 2002, the overall mortality rate was 8.8% (5/57) [61]. Therefore, it seems that due to the good response of HA to treatment, there has been no significant change in the mortality rate in recent years.

Our finding showed that most of the patients experienced complications, the most frequent cases of which were a previous history of abdominal surgery, pelvic colonization due to the use of an IUD, and oral diseases or dental surgery. HA often occurs through the portal vein after the mechanical disruption of the intestinal normal physical barriers in case of surgery intervention and mucosal trauma or via the hepatic artery during hematogenous spread from an oral source [27, 73, 74]. Thus, patients with poor oral hygiene, history of IUD, or intra-abdominal surgery should be evaluated further for HA. Although for preventing HA, we do not have specific measures yet, keeping good personal dental hygiene and, specifically, removing dental plaque may be effective in reducing the density. However, effectiveness of such measures in reducing the probability of incidence of colonization and low-grade periodontal infection with Actinomyces species is not proved [75]. In 13 cases, no disorders were reported that could predispose a patient to HA. Therefore, the liver can be involved without disrupting the tissue barriers [71]. A recent study reported that the infiltrative nature and rapid progression of actinomycosis along with its potential for invading the normal anatomic barriers was probably due to the proteolytic enzymes of Actinomyces species [50]. These microorganisms, by using proteolytic enzymes, can propagate from the liver towards diaphragm and lungs or penetrate the pleural space through lymph vessels or pleuro-peritoneal communications on the diaphragm [42, 76]. Thus, Actinomyces species secrete proteolytic enzymes, penetrate even normal anatomic barriers, and infiltrate the diaphragm; they are complicated by pleural and lung lesions, make cutaneous fistula, and extend to the abdominal and pelvic organs [31].

The clinical signs of HA are usually nonspecific and similar to other infections. However, abdominal pain, fever, and weight loss are the most reported signs among the patients. Anemia and leukocytosis are also other symptoms reported in more than half of the patients. Unlike pyogenic abscess in which 63% of patients have elevated AST levels and 70% of patients have elevated ALT levels, based on the findings of this study, less than one-third of the patients have elevated AST and ALT levels with HA [47, 77]. Increased levels of CA19-9 and CA-125 were reported in five cases. Our finding showed that in patients with HA, tumor marker levels were lower (50–278 U/ml) than those with malignant conditions and at levels greater than 1000 U/ml, the marker’s positive predictive value approached 100% [30]. This might be due to the enhanced production of CA 19–9 from biliary epithelial cells, which is prevalent in the course of benign diseases of the biliary tract, and/or the reduction in hepatobiliary clearance because cholestasis may have led to the increased levels of CA 19–9 in the blood [30]. However, CA19-9 has inadequate sensitivity and specificity to be used as a marker for differentiating HA from liver tumors and appropriate consideration of this marker might turn out useful in the difficult diagnosis. A study has reported that high mobility group box chromosomal protein 1 (HMGB1) may have a potent biological effect on the pathogenesis of HA as a novel cytokine and may be a useful marker in the differential diagnosis of HA [22]. Thus, this marker deserves higher attention in future studies. Clinical manifestation and laboratory tests are non-specific in patients with HA and correct diagnosis of infection is the most difficult step in controlling this infection.

In none of the cases, the imaging modalities result in a definitive diagnosis of infection in the patients. As mentioned, on CT, HA is mainly seen as a single or multiple low-density shadows, which may be accompanied by enhancement. The border is often unclear in this type of images. Thus, it is very difficult to distinguish HA from ordinary bacterial abscesses, inflammatory masses, solitary metastatic lesions, and primary liver masses on CT or MRI [32, 63]. In this context, in eight cases (12%), misdiagnosis based on imaging information led to surgery in patients and perhaps if the HA had been correctly diagnosed in these patients, extensive surgery would not have been necessary at all [12, 20,21,22,23, 50, 53, 63]. In another patient, lesions in liver were not detected by the CT scan either, because they were only approximately 0.5 cm in size, which was beyond the limitations of CT cutting by 1 cm [1]. On the other hand, two studies reported that the use of Contrast Enhanced Ultrasonography (CEUS) might help demonstrate the inflammatory substrate of the lesion and could be very useful for visualizing the lesions and evaluating central liquefaction during the arterial phase as well as the status of the disease. Thus, this technique should be more investigated in future patients [32, 41].

Due to the limitations that exist for imaging modalities, the final diagnosis is made on patohystology, which is the gold standard to confirm or exclude the diagnosis of HA [42]. Histopathologic examination of different samples confirmed the diagnosis of HA in 67% of the patients. On the other hand, histopathologic examination of samples from liver puncture biopsy and liver lobe resection did not help diagnose actinomycosis in 10 and one patient, respectively. Recent studies have reported that, without absolute bacterial identification, the most helpful diagnostic finding is the detection of sulfur granules, also confirmed in the present study with 56% of the patients [38, 78]. However, when only small quantities of tissues are available, sulfur granules can be easily missing and only inflammation or fibrosis may be identified [8]. Therefore, per-cutaneous biopsy diagnosis is not always fruitful and the organism cannot be seen, because the typical sulfur granules are present in the part of the lesion that the biopsy does not reach. Hence, it is recommended that an exploratory laparotomy be adopted for exact diagnosis and treatment [21]. On Hematoxylin and Eosin (H&E) stains, the bacteria are clumped by the radiating fringe of club-like organisms in the sulfur granules and surrounded by neutrophils and lymphocytes. Grocott-Gomori methenamine silver staining is used to identify branching organisms that characterize the presence of actinomycosis. Multinucleated giant cells or granulomas may be seen in a number of cases. However, these morphological results are not specific to actinomycosis, since other microorganisms like Nocardia species and certain fungal or parasitic infections can lead to similar morphological outcomes [1, 34]. Therefore, histopathologic examination of different samples also has limitations for diagnosis and, for some patients, we need to use other ways such as culture and molecular methods for definitive diagnosis of infection.

Our analysis showed that culture was not used to diagnose HA in 37% of the patients and positive results were reported in only 18 patients. The failure rate of culture is quite high often due to growth suppression caused by prior antibiotic therapy, improper specimen gathering and transportation techniques, lack of the proper media, and inadequate culture conditions [8, 70]. On the other hand, while a recent study has reported that positive peripheral blood culture is one of the diagnostic methods for actinomycosis in patients, our results indicated that only two patients had a positive blood culture [37, 61]. Thus, it is difficult to culture Actinomyces while, isolating bacteria from clinical specimens may be necessary to separate nocardiosis or botryomycosis from actinomycosis, diseases that are often morphologically difficult to distinguish. Therefore, direct inoculation of aspirated pus or liver biopsy material into both aerobic and anaerobic blood culture samples may elevate culture sensitivity [79].

The use of molecular methods can be helpful in diagnosing HA, although for only six cases (9%) PCR was used according to the findings of the present study. In one patient, ultrasound guided liver biopsy and diagnostic laparoscopy with excisional biopsy of a lesion did not make an HA diagnosis. Due to the positive Quantiferon-TB test, the liver lesions were thought secondary to disseminated reactivated tuberculosis and the patient underwent RIPE therapy. In this patient, who had a very complex condition, the use of PCR resulted in the correct diagnosis of Actinomyces DNA and hence, the use of appropriate therapies [70]. Accordingly, it can be concluded that each method of diagnosing HA has its limitations and many patients undergo hepatectomy and other extensive surgery due to the difficulty in detecting Actinomyces and distinguishing between Actinomyces abscesses and malignant tumors. Recently, new molecular genetic methods such as PCR for 16S rRNA sequencing and fluorescence in situ hybridization have been developed to achieve faster and more accurate identification in reference or research laboratories [32, 80]. Such methods are highly recommended when there are many challenges to diagnosing HA in the patient.

With correct diagnosis of this infection in patients, the response for treatment was usually good and our finding showed only one death from HA [56]. On the other hand, HA could easily extend transdiaphragmatically to the pericardium and provoke serious illness. Thus, early definitive diagnosis and appropriate antibiotics therapy are critically important [9]. In this context, in one patient, the failure in the first therapy led to transdiaphragmatic spread of HA and its extension into the pericardium caused acute cardiac tamponade [9]. It is noteworthy that Actinomyces spp. are usually highly susceptible to beta-lactams, especially penicillin G or Amoxicillin. Amoxicillin offers high potency in diffusing into inflamed liver tissue and is thus the preferable compound for treating HA [25].

Surgery is another treatment strategy used for patients with HA. There have been many controversies in previous studies about how to use surgery. Our findings showed that 28% of the patients were treated with anti-infection alone and only one case was treated with liver lobe resection alone. One study reported that the outcome of hepatectomy was excellent since no recurrence was observed [27]. Another case also reported that initial treatment with benzyl penicillin and imipenem/cilastatin was ineffective and an exploratory laparotomy and right lobectomy of the liver were performed [49]. Hence, surgery needs to be adopted for the cases in which percutaneous drainage is not possible, for larger lesions in which there is a greater amount of necrotic tissue, and when symptoms are not improved or are aggravated after treatment [28, 36]. On the other hand, as mentioned, in some cases, extended resection was unnecessarily performed. Hence, using preoperative empirical antibiotics and excluding malignant tumors during surgery via frozen biopsy are recommended. Applying this strategy can ensure a reduction in the extent of surgery and postoperative complications in patients with actinomycosis indistinguishable from malignant tumor before surgery [38]. Finally, it should be noted that because of the tendency of the disease to recur, the antibiotic treatment should incorporate high doses and have a prolonged duration. A long-term follow-up is also required to monitor the treatment response and detect any recurrence earlier. The duration of treatment should be individualized based on a number of factors including disease location, severity, and changes in follow-up imaging.


The present study included only PubMed/Medline studies available in English language, which contained an abstract, hence reducing the number of relevant publications. It was not possible to discuss the bias, risks, or individual limitations of the studies, since they were not reported.


HA is a difficult disease to diagnose due to its rarity, nonspecific symptoms, failure of identifying the microorganism, and imitation of more common conditions. In many patients, this infection is confused with other diseases, which may lead to extensive surgery. Therefore, it is recommended that HA be diagnosed correctly before deciding on surgery by using a variety of diagnostic methods considering the fact that, in many patients, infection can be controlled using only antibiotics. Finally, due to the tendency of the disease to recur, the antibiotic treatment must incorporate high doses and have a prolonged duration. A long-term follow-up is also necessary to monitor the treatment response and detect any recurrence early. The duration of treatment should be individualized based on disease location, severity, and changes in follow-up imaging.

Availability of data and materials

The authors confirm that the data supporting the findings of this study is available within the article and its supplementary materials.


  1. 1.

    Wang H-K, Sheng W-H, Hung C-C, Chen Y-C, Liew P-L, Hsiao C-H, Chang S-C. Hepatosplenic actinomycosis in an immunocompetent patient. J Formos Med Assoc. 2012;111(4):228–31.

    PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Joshi V, Koulaouzidis A, McGoldrick S, Tighe M, Tan C. Actinomycotic liver abscess: a rare complication of colonic diverticular disease. Ann Hepatol. 2010;9(1):96–8.

    PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Kanellopoulou T, Alexopoulou A, Tanouli MI, Tiniakos D, Giannopoulos D, Koskinas J, Archimandritis AJ. Primary hepatic actinomycosis. Am J Med Sci. 2010;339(4):362–5.

    PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Ávila F, Santos V, Massinha P, Pereira JR, Quintanilha R, Figueiredo A, Lázaro A, Carrelho S, Coelho JS, Barroso E. Hepatic actinomycosis. GE Port J Gastroenterol. 2015;22(1):19–23.

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Wong JJ, Kinney TB, Miller FJ, Rivera-Sanfeliz G. Hepatic actinomycotic abscesses: diagnosis and management. AJR Am J Roentgenol. 2006;186(1):174–6.

    PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    Smith AJ, Hall V, Thakker B, Gemmell CG. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother. 2005;56(2):407–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    Valour F, Senechal A, Dupieux C, Karsenty J, Lustig S, Breton P, Gleizal A, Boussel L, Laurent F, Braun E, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.

    PubMed  PubMed Central  Google Scholar 

  8. 8.

    Ha YJ, An JH, Shim JH, Yu ES, Kim JJ, Ha TY, Lee HC. A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver. Clin Mol Hepatol. 2015;21(1):80.

    PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Sakaguchi Y, Isowa N, Nakazaki H, Takeda K, Tokuyasu H, Saitoh Y, Soeda T, Ohe T, Tokuyasu Y, Miura H. Acute cardiac tamponade caused by the extension of multiple hepatic actinomycotic abscesses. Intern Med. 2012;51(3):305–8.

    PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Lall T, Shehab TM, Valenstein P. Isolated hepatic actinomycosis: a case report. J Med Case Reports. 2010;4(1):45.

    PubMed Central  Article  Google Scholar 

  11. 11.

    Aslan A, Ayaz E, Inan I, Acar M. Isolated hepatic actinomycosis mimicking hepatocellular carcinoma: Case report and review. AIDM. 2018;5(1–2):55–8.

    Google Scholar 

  12. 12.

    Yang X-X, Lin J-M, Xu K-J, Wang S-Q, Luo T-T, Geng X-X, Huang R-G, Jiang N. Hepatic actinomycosis: report of one case and analysis of 32 previously reported cases. World J Gastroenterol. 2014;20(43):16372.

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Wong VK, Turmezei T, Weston V. Actinomycosis. BMJ. 2011;343:6009.

    Article  Google Scholar 

  14. 14.

    Hickey AJ, Gounder L. Moosa M-YS, Drain PK: a systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis. 2015;15(1):209.

    PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Chegini Z, Didehdar M, Khoshbayan A, Rajaeih S, Salehi M, Shariati A. Epidemiology, clinical features, diagnosis, and treatment of cerebral mucormycosis in diabetic patients: a systematic review of case reports and case series. Mycoses. 2020;63:1264–82.

    PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K. Chapter 7: systematic reviews of etiology and risk. Joanna Briggs Institute Reviewer's Manual The Joanna Briggs Institute 2017:2019–2005.

  17. 17.

    Alawainati M, Al-Khawaja S, Shawqi Z, Alshaikh S. Disseminated actinomycosis a rare cause of abdominal pain: a case report. Oman Med J. 2020;35(2):e117.

    PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Tambay R, Côté J, Bourgault A-M, Villeneuve J-P. An unusual case of hepatic abscess. Can J Gastroenterol. 2001;15:615–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  19. 19.

    Lawson E. Systemic actinomycosis mimicking pelvic malignancy with pulmonary metastases. Can Respir J. 2005;12:153–4.

    PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Lai AT, Lam CM, Ng KK, Yeung C, Ho WL, Poon LT, Ng IO. Hepatic actinomycosis presenting as a liver tumour: case report and literature review. Asian J Surg. 2004;27(4):345–7.

    PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Yu C-Y, Chang W-C, Gao H-W, Chao T-Y, Huang G-S, Hsieh C-B. Metastatic hepatic actinomycosis. Am J Med. 2010;123(9):e9–11.

    PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Wu C-X, Guo H, Gong J-P, Liu Q, Sun H. The role of high mobility group box chromosomal protein 1 expression in the differential diagnosis of hepatic actinomycosis: a case report. J Med Case Rep. 2013;7(1):1–7.

    Article  Google Scholar 

  23. 23.

    Zeng QQ, Zheng XW, Wang QJ, Yu ZP, Zhang QY. Primary hepatic actinomycosis mimicking liver tumour. ANZ J Surg. 2018;88(7–8):E629.

    PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Hernigou J, Dugué L, Maftouh A, Balian C, Charlier A. Appendiceal actinomycosis complicated by multiple hepatic abscesses. J Visc Surg. 2013;150(6):415–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  25. 25.

    Lange C, Hofmann W, Kriener S, Jacobi V, Welsch C, Just-Nuebling G, Zeuzem S. Primary actinomycosis of the liver mimicking malignancy. Z Gastroenterol. 2009;47(10):1062–4.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Harsch I, Benninger J, Niedobitek G, Schindler G, Schneider H, Hahn E, Nusko G. Abdominal actinomycosis: complication of endoscopic stenting in chronic pancreatitis? Endoscopy. 2001;33(12):1065–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Felekouras E, Menenakos C, Griniatsos J, Deladetsima I, Kalaxanis N, Nikiteas N, Papalambros E, Kordossis T, Bastounis E. Liver resection in cases of isolated hepatic actinomycosis: case report and review of the literature. Scand J Infect Dis. 2004;36(6–7):535–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. 28.

    Kanellopoulou T, Alexopoulou A, Tiniakos D, Koskinas J, Archimandritis AJ. Primary hepatic actinomycosis mimicking metastatic liver tumor. J Clin Gastroenterol. 2010;44(6):458–9.

    PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Lakshmana Kumar Y, Javherani R, Malini A, Prasad S. Primary hepatic actinomycosis. Trans R Soc Trop Med Hyg. 2005;99(11):868–70.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    Soardo G, Basan L, Intini S, Avellini C, Sechi LA. Elevated serum CA 19–9 in hepatic actinomycosis. Scand J Gastroenterol. 2005;40(11):1372–3.

    PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Uehara Y, Takahashi T, Yagoshi M, Shimoguchi K, Yanai M, Kumasaka K, Kikuchi K. Liver abscess of Actinomyces israelii in a hemodialysis patient: case report and review of the literature. Intern Med. 2010;49(18):2017–20.

    PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Oe S, Shibata M, Hiura M, Mitsuoka H, Matsuhashi T, Narita R, Abe S, Tabaru A, Hayashida K, Taniguchi H. Refractory primary hepatic actinomycosis with direct infiltration to the diaphragm and thorax: the usefulness of contrast-enhanced ultrasonography. Intern Med. 2014;53(18):2073–8.

    PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Ishiguro T, Takayanagi T, Ikarashi H. Multiple metastatic liver abscesses and intravenous thrombosis due to pelvic actinomycosis. Eur J Obstet Gynecol Reprod Biol. 2016;198:166–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Kim HS, Park NH, Park KA, Kang SB. A case of pelvic actinomycosis with hepatic actinomycotic pseudotumor. Gynecol Obstet Invest. 2007;64(2):95–9.

    PubMed  Article  PubMed Central  Google Scholar 

  35. 35.

    Min KW, Paik SS, Han H, Jang KS. Hepatobiliary and pancreatic: hepatic actinomycosis. J Gastroenterol Hepatol. 2012;27(4):844–844.

    PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Kim YS, Lee BY, Jung MH. Metastatic hepatic actinomycosis masquerading as distant metastases of ovarian cancer. J Obstet Gynaecol Res. 2012;38(3):601–4.

    PubMed  Article  Google Scholar 

  37. 37.

    Seo JY, Yeom J-S, Ko KS. Actinomyces cardiffensis septicemia: a case report. Diagn Microbiol Infect Dis. 2012;73(1):86–8.

    PubMed  Article  Google Scholar 

  38. 38.

    Yang SS, Im YC. Severe abdominopelvic actinomycosis with colon perforation and hepatic involvement mimicking advanced sigmoid colon cancer with hepatic metastasis: a case study. BMC Surg. 2018;18(1):51.

    PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Lee JH, Kim HS, Kim JS, Lee DK, Lim JH. Hepatic actinomycosis with immunoglobulin G4-related liver disease: a case report. Medicine. 2018;97(24):e11146.

    PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Petrache D, Popescu G-A. Successful switch to oral therapy with doxycycline in the case of an actinomycotic hepatic abscess. J Infect Dev Ctries. 2013;7(05):421–3.

    PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Badea R, Chiorean L, Matei D, Seicean A, Andreica V, Botan E. Accidentally ingested foreign body associated with liver actinomycosis: the diagnostic value of imaging. J Gastrointestin Liver Dis. 2013;22(2):209–12.

    PubMed  PubMed Central  Google Scholar 

  42. 42.

    Culafić DM, Lekić NS, Kerkez MD, Mijac DD. Liver actinomycosis mimicking liver tumour. Vojnosanit Pregl. 2009;66(11):924–7.

    PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Basaric D, Lekic N, Djordjevic V, Ceranic M, Barac A, Stevanovic G, Milosevic I. Actinomycotic hepatic abscess in woman with longstanding intrauterine contraceptive device. J Infect Dev Ctries. 2018;12(08):683–6.

    PubMed  Article  PubMed Central  Google Scholar 

  44. 44.

    Llenas-García J, Lalueza-Blanco A, Fernández-Ruiz M, Villar-Silva J, Ochoa M, Lozano F, Lizasoain M, Aguado J. Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade. Infection. 2012;40(3):339–41.

    PubMed  Article  PubMed Central  Google Scholar 

  45. 45.

    Correa Bonito A, Mora-Guzmán I, García-Sanz I, di Martino M, Martín-Pérez E. Liver abscess after endoscopic retrograde cholangiopancreatography with presence of Actinomyces naeslundii. Cir Esp. 2017;95(1):51–2.

    PubMed  Article  PubMed Central  Google Scholar 

  46. 46.

    Lin T-P, Fu L-S, Peng H-C, Lee T, Chen J-T, Chi C-S. Intra-abdominal actinomycosis with hepatic pseudotumor and xanthogranulomatous pyelonephritis in a 6-y-old boy. Scand J Infect Dis. 2001;33(7):551–3.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Chen LW, Chang LC, Shie SS, Chien RN. Solitary actinomycotic abscesses of liver: report of two cases. Int J Clin Pract. 2006;60(1):104–7.

    PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Chao C-T, Liao C-H, Lai C-C, Hsueh P-R. Liver abscess due to Actinomyces odontolyticus in an immunocompetent patient. Infection. 2011;39(1):77–9.

    PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Li P-F, Huang D-W, Peng C-K. Computed tomography of an Actinomyces israelii liver abscess. QJM. 2014;107(8):677–8.

    PubMed  Article  PubMed Central  Google Scholar 

  50. 50.

    Cetinkaya Z, Kocakoc E, Coskun S, Ozercan IH. Primary hepatic actinomycosis. Med Princ Pract. 2010;19(3):196–9.

    PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Coban A, Yetkin G, Kebudi A. Abdominal actinomycosis: a case report. Acta Chir Belg. 2003;103(5):521–3.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  52. 52.

    Buyukavci M, Caner I, Eren S, Aktas O, Akdag R. A childhood case of primary hepatic actinomycosis presenting with cutaneous fistula. Scand J Infect Dis. 2004;36(1):62–3.

    PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Gonenc K, Atahan C, Haluk E, Betul T, Aydin A, Semra C. A case of isolated hepatic actinomycosis causing right pulmonary empyema. Chin Med J. 2006;119(13):1133–5.

    Article  Google Scholar 

  54. 54.

    Guven A, Kesik V, Deveci MS, Ugurel MS, Ozturk H, Koseoglu V. Post varicella hepatic actinomycosis in a 5-year-old girl mimicking acute abdomen. Eur J Pediatr. 2008;167(10):1199–201.

    PubMed  Article  PubMed Central  Google Scholar 

  55. 55.

    Tiftikci A, Vardareli EN, Kaban K, Peker O, Akansel S, Tozun N. Actinomycotic hepatic abscess. Hepatol Int. 2008;2(1):133–5.

    PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    Powell G, Mangalika M. Thoraco-pulmonary and hepatic actinomycosis: an autopsy report. Case Rep. 2011;2011:bcr0920114831.

  57. 57.

    O’Kelly K, Abu J, Hammond R, Jensen M, O’Connor RA, Soomro I. Pelvic actinomycosis with secondary liver abscess, an unusual presentation. Eur J Obstet Gynecol Reprod Biol. 2012;163(2):239–40.

    PubMed  Article  PubMed Central  Google Scholar 

  58. 58.

    Mukundan G, Fishman EK. Pulmonary and hepatic actinomycosis: atypical radiologic findings of an uncommon infection. Clin Imaging. 2000;24(2):78–80.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    Hilfiker ML. Disseminated actinomycosis presenting as a renal tumor with metastases. J Pediatr Surg. 2001;36(10):1577–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  60. 60.

    Riegert-Johnson DL, Sandhu N, Rajkumar SV, Patel R. Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis. Clin Infect Dis. 2002;35(5):636–7.

    PubMed  Article  PubMed Central  Google Scholar 

  61. 61.

    Sharma M, Briski LE, Khatib R. Hepatic actinomycosis: an overview of salient features and outcome of therapy. Scand J Infect Dis. 2002;34(5):386–91.

    PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Islam T, Athar MN, Athar MK, Usman MHU, Misbah B. Hepatic actinomycosis with infiltration of the diaphragm and right lung: a case report. Can Respir J. 2005;12:336–7.

    PubMed  Article  PubMed Central  Google Scholar 

  63. 63.

    Wayne MG, Narang R, Chauhdry A, Steele J. Hepatic actinomycosis mimicking an isolated tumor recurrence. World J Surg Oncol. 2011;9(1):70.

    PubMed  PubMed Central  Article  Google Scholar 

  64. 64.

    Jaqua NT, Smith AJ, Shin TT, Jahanmir J. Actinomyces naeslundii and Eikenella corrodens as rare causes of liver abscesses. Case Rep. 2013;2013:bcr2013009613.

  65. 65.

    Sahay S, McKelvy BJ. Actinomycosis presenting as recurrent hepatic abscess. Am J Med. 2017;130(1):e21–2.

    PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Xing J, Rodriguez EF, Monaco SE, Pantanowitz L. Cytopathology of hepatobiliary-related actinomycosis. Acta Cytol. 2016;60(2):179–84.

    PubMed  Article  PubMed Central  Google Scholar 

  67. 67.

    Kothadia JP, Samant H, Olivera-Martinez M. Actinomycotic hepatic abscess mimicking liver tumor. Clin Gastroenterol Hepatol. 2018;16(8):e86.

    PubMed  Article  PubMed Central  Google Scholar 

  68. 68.

    Ridha A, Oguejiofor N, Al-Abayechi S, Njoku E. Intra-abdominal actinomycosis mimicking malignant abdominal disease. Case Rep Infect Dis. 2017;2017:1972023.

  69. 69.

    Grossen A, Magguilli M, Thai TC, Salem G. Hepatic actinomycosis in a patient with retained common bile duct stent. ACG Case Rep J. 2019;6(9):e00219.

  70. 70.

    Murphy P, Mar WA, Allison D, Cornejo GA, Setty S, Giulianotti PC. Hepatic actinomycosis–A potential mimicker of malignancy. Radiol Case Rep. 2020;15(2):105–9.

    PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Miyamoto MI, Fang FC. Pyogenic liver abscess involving Actinomyces: case report and review. Clin Infect Dis. 1993;16(2):303–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  72. 72.

    Meyer P, Nwariaku O, McCelland R, Gibbons D, Leach F, Sagalowsky AI, Simmang C, Jeyarajah D. Rare presentation of actinomycosis as an abdominal mass. Dis Colon Rectum. 2000;43(6):872–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  73. 73.

    Kasano Y, Tanimura H, Yamaue H, Hayashido M, Umano Y. Hepatic actinomycosis infiltrating the diaphragm and right lung. Am J Gastroenterol. 1996;91(11):2418–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. 74.

    Cheng YF, Hung CF, Liu YH, Ng KK, Tsai CC. Hepatic actinomycosis with portal vein occlusion. Gastrointest Radiol. 1989;14(1):268–70.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  75. 75.

    Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis. 1998;26:1255–61.

    PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Ubeda B, Vilana R, Bianchi L, Pujol T. Primary hepatic actinomycosis: association with portal vein thrombosis. AJR Am J Roentgenol. 1995;165(1):231–2.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  77. 77.

    Sugano S, Matuda T, Suzuki T, Makino H, Iinuma M, Ishii K, Ohe K, Mogami K. Hepatic actinomycosis: case report and review of the literature in Japan. J Gastroenterol. 1997;32(5):672–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  78. 78.

    Lee JD, Kim PG, Jo H, Park DH, Seo E. A case of primary hepatic actinomycosis. J Korean Med Sci. 1993;8(8):385–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  79. 79.

    Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology. 1988;95(5):1351–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  80. 80.

    Hansen J, Fjeldsøe-Nielsen H, Sulim S, Kemp M, Christensen J. Actinomyces species: a Danish survey on human infections and microbiological characteristics. Open Microbiol J. 2009;3:113.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references


Not applicable.


Not applicable.

Author information




AS and AK conceived and designed the study. AS and ZC contributed in comprehensive research. AS, MD, ZC and AK wrote the paper. AT analyzed the cases. MD and AT participated in manuscript editing. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Aref Shariati.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1

. Various findings that led to the diagnosis of hepatic actinomycosis in different patients. Tables S2. Radiological and anatomic characteristics of hepatic actinomycosis. Tables S3. Prophylaxis and Empirical antibiotics therapy in patients with hepatic actinomycosis. Tables S4. Microbiological features of hepatic actinomycosis.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chegini, Z., Didehdar, M., Tabaeian, S.P. et al. A systematic review of case reports of hepatic actinomycosis. Orphanet J Rare Dis 16, 192 (2021).

Download citation


  • Actinomycosis
  • Liver abscess
  • Hepatic actinomycosis
  • Actinomyces species
  • Diagnosis